Clinical Trial Update: NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous NY-ESO-1–specific T cells in advanced NY-ESO-1-expressing sarcomas given with palliative radiation; the study has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• NY-ESO-1–specific T cells (NY-ESO-1–specific T cells)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2017-07-05